Such a concept is also supported by the recent finding that etanercept, a recombinant fusion protein of human tumor necrosis factor-α (TNF-α) receptor and immunoglobulin G1, can relieve fatigue and symptoms of depression associated with CNS inflammatory disease or peripheral inflammation [58-60] despite its poor transport across the BBB [61]. The gene discussed is TNF; the disease is major depressive disorder.